URI enters its July 22 earnings date with the Street firmly re-rating higher — and options markets doing the opposite, quietly turning less bearish than they've been all year.
The analyst story this week is unusually clean. Three firms lifted targets in quick succession, and one upgraded outright. BNP Paribas moved to Outperform on Sunday with a $1,320 target, the highest on the Street. UBS — which had already raised its target to $1,145 in early June — returned Tuesday to push again, this time to $1,300, reaffirming Buy. Keybanc and Bank of America both lifted targets earlier in the week, to $1,250 and $1,195 respectively, each maintaining positive ratings. The consensus now clusters firmly above the current price of $1,132.89, with the mean target at roughly $1,127 — essentially in line with where the stock trades, suggesting the recent 14% one-month rally has absorbed most of the near-term upside already priced in by the Street. One outlier remains: Barclays held its Underweight with a $715 target, a level so far below current trading that it reads as a structural bear call rather than a near-term view.
Options positioning adds an interesting counterpoint. The options market has actually become the least defensively positioned it has been in over a year. The put/call ratio dropped to 1.08, more than two and a half standard deviations below its 20-day average of 1.21 — the lowest reading of the past 52 weeks. For a stock that typically carries a notably put-heavy options book, this is a meaningful shift. It points to a market where call buying has picked up and downside hedging has faded, broadly consistent with the momentum into a Q2 print that investors appear to be approaching with less anxiety than usual.
Short interest does nothing to complicate that picture. Shorts represent just 2.3% of free float — a low level that has drifted sideways for months, ticking up about 4.7% on the week but still well below June's early peaks. Borrow cost climbed to 0.50%, a one-month high and up roughly 19% week-on-week, but in absolute terms remains near zero — this is not a stressed lending market. Availability is extraordinarily loose at over 6,400%, meaning there are roughly 64 shares available to borrow for every one currently lent out. The borrow market tells a story of minimal short conviction, not a setup with squeeze potential in either direction.
The earnings history adds genuine texture here. The most recent Q1 print — on April 23 — produced a one-day move of over 21% and a five-day gain approaching 20%. That followed an analyst-driven re-rating cluster in late April, almost identical in shape to what is happening now. The forward EPS momentum factor scores in the 94th percentile for 12-month estimate upgrades, consistent with a cycle where consensus has been repeatedly revised upward. The stock's earnings record is not one of quiet beats — it swings hard when results arrive.
The EV/EBITDA multiple of 10.3x has expanded about a full point over the past month, reflecting the stock's run. Price-to-earnings at 21.5x and price-to-book at 6.6x are both up meaningfully on the month. Value scores remain the weakest factor at around the 45th percentile, while the 12-month forward EPS growth factor sits near the top of the universe. Nearest peer HRI gave back 2% on the day URI gained 0.9%, while CTOS and CNM both posted solid weeks of roughly 5% and 4% respectively — a mixed backdrop that suggests URI's own momentum is doing most of the work.
What to watch on July 22 is whether the revenue trajectory holds alongside margins — the bull case rests on rental penetration gains and capex-driven demand, while the bear case centres on used equipment normalisation and the point at which EBITDA margins stop expanding.
See the live data behind this article on ORTEX.
Open URI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
